News
-
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders